OakChart

Modular Medical Inc

MODDHealthcare·Medical Devices·USA·Nano·NASD·Nov 11 • 9:40 AM ET

1.83+0.16 (9.58%)
2026-11-11 15:43 CET
Market cap
15.86 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-28.03 USD m
Free cash flow, TTM
-28.04 USD m
EPS diluted, TTM
-10.11
P/E
-
Compare

Price

MODD against its 20, 50 and 200-day averages
2050200
5.0010.001.2M2.4MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26MODDclose 1.8320-day 1.8050-day 2.20200-day 4.751.83

90.2% under 18.67 on 3 Nov 2025. Last 15 sessions, 67.4% high to low

Profile

MODD
52-week range, 4% of the way up
1.2017.09

Modular Medical, Inc. is a development stage company, which engages in the provision of insulin pump technology. It focuses on the design, development, and commercialization of insulin pumps to serve the diabetes market. The company was founded by Paul M. DiPerna on October 22, 1998 and is headquartered in San Diego, CA.

Employees51
IPODec 13, 2018
Beta0.33
ATR, 14d0.30
Rel volume0.06
Short float3.71%
Insider own7.30%
Inst own24.31%

Snapshot

6 groups

Valuation

Index-
Market Cap17.38M
Enterprise Value13.74M
Income-28.03M
Sales0.00M
Book/sh1.93
Cash/sh0.41
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees51
IPODec 13, 2018

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B0.95
P/C4.43
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio3.25
Current Ratio3.25
Debt/Eq0.03
LT Debt/Eq0.00
Option/ShortNo / Yes

Earnings

EPS (ttm)-10.11
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y31.39% 19.08%
Sales past 3/5Y- -
EPS Y/Y TTM33.94%
Sales Y/Y TTM-
EPS Q/Q67.88%
Sales Q/Q-
Earnings-
EPS/Sales Surpr.0.00% -

Ownership

Insider Own7.30%
Insider Trans0.00%
Inst Own24.31%
Inst Trans4.71%
ROA-212.13%
ROE-247.94%
ROIC-260.37%
Gross Margin-
Oper. Margin-
Profit Margin-
SMA201.74%
SMA50-16.72%
SMA200-61.46%
Trades-

Technical

Shs Outstand9.50M
Shs Float8.80M
Short Float3.71%
Short Ratio1.23
Short Interest0.33M
52W High17.09 -89.29%
52W Low1.20 53.14%
Volatility26.67% 19.39%
ATR (14)0.30
RSI (14)48.33
Beta0.33
Rel Volume0.06
Avg Volume264.91K
Volume1,202

Performance

Perf Week9.58%
Perf Month-14.49%
Perf Quarter-2.14%
Perf Half Y-44.55%
Perf YTD-83.25%
Perf Year-87.54%
Perf 3Y-95.08%
Perf 5Y-99.36%
Perf 10Y-
Recom1.00
Target Price240.00
Prev Close1.67
Price1.83
Change %9.58%

Peers

Mkt cap
TickerCompanyMkt cap
PODDInsulet Corp10.22B
TNDMTandem Diabetes Care Inc1.33B
BBNXBeta Bionics Inc935.89M
MMEDMiniMed Group Inc4.95B
SENSSenseonics Holdings Inc545.07M
DXCMDexcom Inc29.72B
ABTAbbott Laboratories190.32B
TRIBTrinity Biotech Plc ADR3.78M
PFSAProfusa Inc0.33M

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B

News

latest 14 of 206
  • Modular Medical Completes Comprehensive Patient Market Research Study with Thrivable, Reinforcing Strong Interest in Simplified Insulin Delivery (ACCESSWIRE) +39.10%
  • Modular Medical Announces Positive Notified Body Decision on ISO 13485:2016 Certification (ACCESSWIRE)
  • Modular Medical Launches Digital Learning Tools to Support Adoption of Pivot Insulin Delivery System (ACCESSWIRE) +10.77%
  • Modular Medical to Present at the Webull Emerging & Innovative Companies Webinar on October 14th (ACCESSWIRE)
  • iAccess Alpha Virtual Best Ideas Fall Investment Conference, September 15-16, 2026 (ACCESSWIRE) -23.37%
  • Loading…
  • Modular Medical to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 on September 15-16, 2026 (ACCESSWIRE)
  • Modular Medical Announces Contract with National U.S. Pharmacy Benefit Manager, Expanding Access to Pivot Tubeless Patch Pump (ACCESSWIRE) +7.60%
  • Modular Medical Announces FDA Clearance of Pivot Tubeless Insulin Patch Pump Enhancements (ACCESSWIRE)
  • Registration is Now Open for Tribe Public's CEO Presentation and Q&A Webinar Event Titled ''The Road To Revenue: Modular Medical's Strategy For Launching Pivot'' Featuring Modular Medical CEO - Friday, September 4, 2026 (ACCESSWIRE)
  • Modular Medical to Participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference (ACCESSWIRE) -6.94%
  • Modular Medical Announces Launch of Pivot Insulin Delivery System Across Five Key U.S. Markets Beginning October 2026 (ACCESSWIRE) -7.11%
  • Modular Medical Announces Formation of Pivot Innovation Council and Appointment of Robert Gabbay, MD, PhD, FACP as Chairman (ACCESSWIRE)
  • Modular Medical and IMO Health Launch Strategic Pilot to Enable Real Time Insulin Pump Patient Identification Into Electronic Health Records (ACCESSWIRE) -22.67%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2024Q32025-02-26-3.600-3.600-3.8120.000.001
2024Q22024-11-27-4.200-4.200-4.2000.000.001
2024Q12024-08-28-3.600-3.600-3.6630.000.001
2023Q42024-05-29-4.800-6.000-4.3140.000.001
2023Q32024-02-28-6.900-5.250-7.0130.000.002
2023Q22023-11-29-5.700-6.450-5.5910.000.002
2023Q12023-08-30-6.600-6.600-6.5570.000.001
2022Q42023-08-14-9.900-10.200-9.7850.000.002
2022Q32023-06-26-9.300-10.650-9.2220.000.002
2022Q22023-01-30-9.600--9.4840.00-2
2022Q12022-11-29-9.900--9.7700.00-1
2021Q42022-08-11-16.800--15.6000.00-3
2021Q32022-04-07-22.800--22.8570.00--
2024Q4---3.300-3.466-0.001
2025Q1---3.000-3.704-0.201
2025Q2---3.000-4.205-0.401

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2021FY-82.200-78.000-82.1100.000.10
2022FY-38.400-38.700-38.2670.000.00
2023FY-23.400-25.200-23.4000.000.00
2024FY--14.400-15.260-0.00
2025FY--11.700-12.360-3.20

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2024Q4S2025-02-261000.000.000.00
2024Q4S2025-02-081000.000.000.00
2024Q4S2024-11-271010.000.000.00
2024Q4S2024-11-251010.000.000.00
2024Q4S2024-08-281000.400.400.40
2024Q4S2024-05-291000.400.400.40
2024Q4S2024-03-041000.400.400.40
2024Q4S2024-03-031000.400.400.40
2024Q4S2024-03-021000.400.400.40
2024Q4S2024-03-011000.400.400.40
2024Q4R2025-02-26100-0.11-0.11-0.11
2024Q4R2024-11-27100-0.11-0.11-0.11
2024Q4R2024-10-10100-0.11-0.11-0.11
2024Q4R2024-08-28110-0.11-0.11-0.11

Estimate history

EPS, annual-4.41-13.777-26.806-35.634-82.11-38.267-23.421-15.26-12.36-10.1146
Period201720182019202020212022202320242025TTM
EPS, quarterly-3.663-4.33-3.812-3.466-3.704-4.205-3.349-1.371-1.19
PeriodQ1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Sales, annual0000000000
Period201720182019202020212022202320242025TTM
Sales, quarterly000000000
PeriodQ1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Shares, annual0.1780.1980.1990.210.3490.3651.0821.794.6615.571
Period201720182019202020212022202320242025MRQ
Shares, quarterly1.0851.1461.3551.791.8422.0392.594.6615.571
PeriodQ1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue0.000.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A1.761.671.430.770.360.200.180.040.01
Gross Profit-1.76-1.67-1.43-0.77-0.36-0.20-0.18-0.04-0.01
Selling, General and Administrative Excl. Other25.5325.8917.6116.7613.5214.737.155.312.56
Research and Development17.4518.3014.7012.889.067.734.083.031.88
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-27.29-27.56-19.05-17.53-13.88-14.93-7.34-5.35-2.58
Interest Expense0.000.000.000.000.002.750.040.000.00
Unusual Expense0.830.830.000.000.001.320.000.00-
Net Income Before Taxes-28.02-28.24-18.82-17.47-13.88-18.63-7.38-5.32-2.54
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income-28.03-28.24-18.82-17.47-13.88-18.63-7.38-5.32-2.54
Net Income From Continuing Operations-28.03-28.24-18.82-17.47-13.88-18.63-7.38-5.32-2.54
Net Income-28.03-28.24-18.82-17.47-13.88-18.63-7.38-5.32-2.54
EPS (Recurring)-5.03-12.10-15.26-23.42-38.27-78.03-35.63-26.81-13.78
EPS (Basic, Before Extraordinaries)-10.11-12.36-15.26-23.42-38.27-82.11-35.63-26.81-13.78
EPS (Diluted)-10.11-12.36-15.26-23.42-38.27-82.11-35.63-26.81-13.78
EBITDA-25.53-25.89-17.61-16.76-13.52-14.73-7.15-5.31-2.56
Non-Operating Income (Expense)0.100.150.230.060.000.370.000.030.04
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.101.401.862.132.212.940.900.580.39
Shares Outstanding5.574.661.791.080.360.350.210.200.20
Market Capitalization15.8615.8658.5439.4015.8846.0399.264.293.56

Income statement, quarterly

Currency USD, millions
Metric2026Q12025Q42025Q32025Q22025Q12024Q42024Q32024Q2
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.500.440.430.390.410.330.280.26
Gross Profit-0.50-0.44-0.43-0.39-0.41-0.33-0.28-0.26
Selling, General and Administrative Excl. Other6.045.246.817.446.394.654.574.74
Research and Development3.873.404.975.204.723.613.573.44
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-6.54-5.68-7.24-7.83-6.80-4.98-4.85-5.00
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.710.130.000.000.000.000.00
Net Income Before Taxes-6.49-6.39-7.36-7.79-6.70-4.93-4.80-4.95
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-6.49-6.39-7.36-7.79-6.70-4.93-4.80-4.96
Net Income From Continuing Operations-6.49-6.39-7.36-7.79-6.70-4.93-4.80-4.96
Net Income-6.49-6.39-7.36-7.79-6.70-4.93-4.80-4.96
EPS (Recurring)-1.19-1.26-3.31-4.21-3.70-3.47-3.81-4.33
EPS (Basic, Before Extraordinaries)-1.19-1.37-3.35-4.21-3.70-3.47-3.81-4.33
EPS (Diluted)-1.19-1.37-3.35-4.21-3.70-3.47-3.81-4.33
EBITDA-6.04-5.24-6.81-7.44-6.39-4.65-4.57-4.74
Non-Operating Income (Expense)0.05-0.000.010.040.100.050.050.04
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.45-0.400.420.640.720.370.410.79
Shares Outstanding5.574.662.592.041.841.791.361.15
Market Capitalization15.8624.6128.2942.8141.1858.5455.7177.33

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments6.9413.109.233.809.081.473.126.554.30
Short Term Receivables0.020.070.150.000.000.000.000.000.00
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets0.580.350.320.250.310.180.060.020.02
Total Current Assets7.5413.529.704.059.391.653.196.574.31
Net Property, Plant & Equipment7.235.224.113.200.360.500.570.080.01
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets-0.000.000.000.000.000.000.000.00
Other Assets0.060.000.000.000.100.100.100.010.01
Total Assets14.8318.7313.817.259.852.253.866.654.33
Short Term Debt Incl. Current Port. of LT Debt0.390.420.370.360.142.630.090.000.00
Accounts Payable0.990.340.800.290.300.170.360.000.00
Other Current Liabilities0.490.500.280.340.520.500.210.180.02
Total Current Liabilities1.871.261.460.980.973.300.660.180.02
Long Term Debt0.000.390.821.190.040.180.180.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.040.140.000.00
Total Liabilities1.871.662.272.171.013.520.980.180.02
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity12.9617.0811.545.088.84-1.282.886.474.32
Total Shareholders Equity12.9617.0811.545.088.84-1.282.886.474.32
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity12.9617.0811.545.088.84-1.282.886.474.32
Total Liabilities & Stockholders Equity14.8318.7313.817.259.852.253.866.654.33
Book Value Per Share2.789.5410.6613.9125.34-6.0714.5032.6624.32
Tangible Book Value Per Share2.789.5410.6613.9125.34-6.0714.5032.6624.32
Full-Time Employees5154403825201364
Price to Book Ratio0.863.4310.253.135.21-77.841.490.50-68.83
Return on Assets-168.27-115.69-165.97-162.41-308.12-241.63-101.24-46.23-30.42
Return on Equity-188.05-131.58-210.34-199.51-492.82-920.36-113.79-47.06-31.96
Return on Invested Capital-217.93-107.75-141.43-221.50-209.91--174.05-39.23-15.26
Quick Ratio4.0310.696.664.139.680.504.8236.71278.81
Current Ratio4.0310.696.664.139.680.504.8236.71278.81

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-28.03-28.24-18.82-17.47-13.88-18.63-7.38-5.32-2.54
Depreciation1.761.671.430.770.360.200.180.040.01
Other Funds (Non Cash)2.352.622.432.742.937.761.350.800.55
Funds from Operations-23.92-23.95-14.96-13.96-10.60-10.68-5.85-4.48-1.97
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-0.430.19-0.760.01-0.410.42-0.060.390.17
Cash from Operating Activities-24.35-23.75-15.72-13.95-11.01-10.26-5.91-4.09-1.81
Capital Expenditures-3.69-3.93-2.49-1.70-1.64-0.05-0.11-0.26-0.08
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-3.69-3.93-2.49-1.70-1.64-0.05-0.11-0.26-0.08
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock24.4421.5322.0821.097.3713.791.790.924.14
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock24.4421.5322.0821.097.3713.791.790.924.14
Proceedsfrom Stock Options4.791.882.1120.347.3713.791.790.924.14
Issuance or Reduction of Debt, Net0.000.000.000.000.004.142.580.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.00-0.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.00-0.00
Cash from Financing Activities24.4421.5322.0821.097.3717.924.360.924.14
Net Change in Cash-3.60-6.153.865.43-5.287.61-1.65-3.432.26
Free Cash Flow-28.04-27.68-18.21-15.65-12.65-10.31-6.02-4.36-1.89
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q12025Q42025Q32025Q22025Q12024Q4
Cash & Short Term Investments3.926.942.945.327.5213.10
Short Term Receivables0.240.020.000.030.080.07
Inventories0.000.000.000.000.000.00
Other Current Assets0.690.580.530.610.690.35
Total Current Assets4.847.543.475.958.2913.52
Net Property, Plant & Equipment7.357.236.797.035.885.22
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets--0.000.000.000.00
Other Assets0.060.060.000.000.000.00
Total Assets12.2514.8310.2612.9714.1718.73
Short Term Debt Incl. Current Port. of LT Debt0.280.390.460.450.440.42
Accounts Payable0.600.991.012.881.070.34
Other Current Liabilities0.610.490.710.710.550.50
Total Current Liabilities1.491.872.184.042.051.26
Long Term Debt0.000.000.040.160.280.39
Provision for Risks Charges0.000.002.160.000.000.00
Other Liabilities0.000.000.000.000.000.00
Total Liabilities1.491.874.384.212.331.66
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity10.7612.965.888.7711.8417.08
Total Shareholders Equity10.7612.965.888.7711.8417.08
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity10.7612.965.888.7711.8417.08
Total Liabilities & Stockholders Equity12.2514.8310.2612.9714.1718.73
Book Value Per Share1.932.782.274.306.439.54
Tangible Book Value Per Share1.932.782.274.306.439.54
Full-Time Employees515169--54
Price to Book Ratio0.861.904.814.883.483.43
Return on Assets-212.13-168.27-239.01-222.79-176.46-115.69
Return on Equity-247.94-188.05-331.77-308.87-215.41-131.58
Return on Invested Capital-60.26-49.31-124.30-87.23-55.29-28.20
Quick Ratio3.254.031.591.474.0410.69
Current Ratio3.254.031.591.474.0410.69

Cash flow, quarterly

Currency USD, millions
Metric2026Q12025Q42025Q32025Q22025Q12024Q4
Net Income-6.49-6.39-7.36-7.79-6.70-4.93
Depreciation0.500.440.430.390.410.70
Other Funds (Non Cash)0.450.420.670.810.730.38
Funds from Operations-5.54-5.53-6.26-6.58-5.57-3.85
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.43-0.28-0.891.170.19-0.46
Cash from Operating Activities-5.97-5.82-7.16-5.41-5.37-4.31
Capital Expenditures-0.69-1.00-1.22-0.77-0.93-0.95
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.69-1.00-1.22-0.77-0.93-0.95
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock3.6410.826.003.980.7311.37
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock3.6410.826.003.980.7311.37
Proceedsfrom Stock Options3.64-4.856.000.000.73-7.34
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities3.6410.826.003.980.7311.37
Net Change in Cash-3.024.00-2.38-2.21-5.576.11
Free Cash Flow-6.66-6.82-8.38-6.18-6.31-5.26

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-303.71%0.3M8.8M270.86K
2026-10-153.17%0.3M8.8M281.94K
2026-09-304.41%0.4M8.8M272.36K
2026-09-155.79%0.4M7.6M293.19K
2026-08-314.92%0.4M7.6M242.79K
2026-08-146.10%0.5M7.6M155.31K
2026-07-313.75%0.2M5.0M95.37K
2026-07-154.25%0.2M5.0M68.66K
2026-06-303.23%0.2M5.0M72.77K
2026-06-151.84%0.1M5.0M43.68K
2026-05-292.28%0.1M5.0M56.85K
2026-05-152.53%0.1M5.0M55.52K
2026-04-302.04%0.1M5.0M54.22K
2026-04-152.82%0.1M4.3M49.75K
2026-03-311.36%0.1M4.4M34.42K
2026-03-131.20%0.1M4.4M26.19K
2026-02-270.42%0.0M2.5M13.22K
2026-02-130.40%0.0M2.5M12.30K
2026-01-300.39%0.0M2.5M27.66K
2026-01-150.55%0.0M2.5M27.72K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10SCHEDULE 13G/ASEC
2026-11-094Statement of changes in beneficial ownership of securities2026-10-29SEC
2026-11-094Statement of changes in beneficial ownership of securities2026-10-29SEC
2026-11-06SCHEDULE 13G/ASEC
2026-11-05SCHEDULE 13GSEC
2026-10-29S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-10-288-KCurrent report2026-10-23SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-01ARSAnnual report to security holders. 2026-03-31SEC
2026-10-01DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-10-23SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-09-298-KCurrent report2026-09-24SEC
2026-09-038-KCurrent report2026-09-03SEC
2026-08-18EFFECTEffectiveness filing by commission orderSEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-13SCHEDULE 13GSEC
2026-08-07SCHEDULE 13GSEC
2026-08-05S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
AWM Investment Company, Inc.8.15%
Solas Capital Management, LLC8.10%
Bleichroeder LP6.23%
683 Capital Management, LLC2.40%
VANGUARD CAPITAL MANAGEMENT LLC1.91%
BARD ASSOCIATES INC1.88%
NORTHERN TRUST CORP1.15%
GEODE CAPITAL MANAGEMENT, LLC0.79%
Sio Capital Management, LLC0.48%
VANGUARD FIDUCIARY TRUST CO0.36%

Funds

Fund% owned
VANGUARD EXTENDED MARKET INDEX FUND0.99%
VANGUARD TOTAL STOCK MARKET INDEX FUND0.76%
Fidelity Extended Market Index Fund0.47%
Fidelity Series Total Market Index Fund0.11%
Fidelity Total Market Index Fund0.09%
Fidelity Nasdaq Composite Index Fund0.06%

OakChart. MODD. Cached 15 minutes.

Some panels did not load: ratings, insider.